Edition:
India

Aprea Therapeutics Inc Qtrly Net Loss Per Share, Basic And Diluted $5.29

Nov 14 (Reuters) - Aprea Therapeutics Inc ::APREA THERAPEUTICS REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS.APREA THERAPEUTICS INC - QTRLY NET LOSS PER SHARE , BASIC AND DILUTED $5.29.

Friday, 15 Nov 2019

Tricida Reports Q3 Loss Per Share $0.89

Nov 14 (Reuters) - Tricida Inc ::TRICIDA ANNOUNCES THIRD QUARTER 2019 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.89.Q3 EARNINGS PER SHARE ESTIMATE $-0.89 -- REFINITIV IBES DATA.AS OF SEPTEMBER 30, 2019, CASH, CASH EQUIVALENTS & INVESTMENTS WERE $363.6 MILLION.AS OF SEPTEMBER 30, 2019, CASH, CASH...

Friday, 15 Nov 2019

Celsion Corporation Reports Qtrly Loss Per Share of $0.25

Nov 14 (Reuters) - Celsion Corp ::CELSION CORPORATION REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.CELSION CORP - QTRLY LOSS PER SHARE $0.25.CELSION CORP - ENDED Q3 OF 2019 WITH $18.8 MILLION IN CASH, INVESTMENT SECURITIES AND INTEREST RECEIVABLE.CELSION CORP - BELIEVES...

Friday, 15 Nov 2019

Plus Therapeutics Reports Q3 Earnings Per Share $0.03

Nov 14 (Reuters) - Plus Therapeutics Inc ::PLUS THERAPEUTICS REPORTS THIRD QUARTER 2019 FINANCIAL AND BUSINESS RESULTS.Q3 EARNINGS PER SHARE $0.03 FROM CONTINUING OPERATIONS.Q3 2019 CONTRACT REVENUES WERE $4.8 MILLION, COMPARED TO $0.5 MILLION FOR Q3 2018.ENDED QUARTER WITH APPROXIMATELY $16.8...

Friday, 15 Nov 2019

Expansion & New Markets

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.